PA
PBE icon

PFG Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

PFG Advisors’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+2,364
New +$195K 0.01% 764
2022
Q3 		– Sell
-3,469
Closed -$200K – 539
2022
Q2 		$200K Sell
3,469
-38
-1% -$2.19K 0.02% 369
2022
Q1 		$218K Sell
3,507
-19,412
-85% -$1.18M 0.02% 383
2021
Q4 		$1.63M Sell
22,919
-8,828
-28% -$639K 0.16% 181
2021
Q3 		$2.38M Sell
31,747
-80
-0.3% -$6.1K 0.26% 109
2021
Q2 		$2.46M Buy
31,827
+920
+3% +$68.4K 0.28% 99
2021
Q1 		$2.28M Buy
30,907
+440
+1% +$33.3K 0.29% 101
2020
Q4 		$2.14M Buy
30,467
+100
+0.3% +$6.33K 0.36% 75
2020
Q3 		$1.83M Buy
30,367
+147
+0.5% +$8.64K 0.35% 79
2020
Q2 		$1.81M Buy
30,220
+140
+0.5% +$7.63K 0.41% 76
2020
Q1 		$1.59M Sell
30,080
-90
-0.3% -$4.69K 0.43% 75
2019
Q4 		$1.66M Sell
30,170
-225
-0.7% -$11.7K 0.41% 77
2019
Q3 		$1.41M Buy
30,395
+3
+0% +$154 0.39% 72
2019
Q2 		$1.6M Buy
30,392
+232
+0.8% +$12K 0.43% 61
2019
Q1 		$1.57M Sell
30,160
-795
-3% -$42K 0.48% 55
2018
Q4 		$1.6M Buy
+30,955
New +$1.59M 0.5% 56

Other funds holding PBE

YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
CCMG
Connecticut Capital Management Group Milford, Connecticut $124M AUM
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
FPB
First PREMIER Bank Sioux Falls, South Dakota $619M AUM 20.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

PFG Advisors's PBE Position: Q2 2026 in Review

PFG Advisors opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q2 2026: 2,364 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #764 among its holdings. This is a return to the name: PFG Advisors previously reported a position in PBE as recently as Q2 2022.

PFG Advisors first reported a position in PBE in Q4 2018 and has held it in 16 quarters since. The position peaked at $2.46M in Q2 2021. 12 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

  • PFG Advisors held 2,364 shares of Invesco Biotechnology & Genome ETF worth $212K as of Q2 2026.
  • Invesco Biotechnology & Genome ETF was a new PFG Advisors position in Q2 2026.
  • Invesco Biotechnology & Genome ETF made up 0.01% of PFG Advisors's portfolio in Q2 2026, its #764 holding.
  • PFG Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q4 2018 and has held it in 16 quarters since.
  • PFG Advisors's Invesco Biotechnology & Genome ETF position peaked at $2.46M in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.